Related Experiment Video
Updated: Jun 27, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic
María Fernández-Velasco1, Angélica Rueda, Nicoletta Rizzi
1Institut National de la Santé et de la Recherche Médicale, U637, Université de Montpellier, Montpellier, France.
Abstract:
Cardiac ryanodine receptor (RyR2) mutations are associated with autosomal dominant catecholaminergic polymorphic ventricular tachycardia, suggesting that alterations in Ca(2+) handling underlie this disease. Here we analyze the underlying Ca(2+) release defect that leads to arrhythmia in cardiomyocytes isolated from heterozygous knock-in mice carrying the RyR2(R4496C) mutation. RyR2(R4496C-/-) littermates (wild type) were used as controls. [Ca(2+)](i) transients were obtained by field stimulation in fluo-3-loaded cardiomyocytes and viewed using confocal microscopy. In our basal recording conditions (2-Hz stimulation rate), [Ca(2+)](i) transients and sarcoplasmic reticulum Ca(2+) load were similar in wild-type and RyR2(R4496C) cells. However, paced RyR2(R4496C) ventricular myocytes presented abnormal Ca(2+) release during the diastolic period, viewed as Ca(2+) waves, consistent with the occurrence of delayed afterdepolarizations. The occurrence of this abnormal Ca(2+) release was enhanced at faster stimulation rates and by beta-adrenergic stimulation, which also induced triggered activity. Spontaneous Ca(2+) sparks were more frequent in RyR2(R4496C) myocytes, indicating increased RyR2(R4496C) activity. When permeabilized cells were exposed to different cytosolic [Ca(2+)](i), RyR2(R4496C) showed a dramatic increase in Ca(2+) sensitivity. Isoproterenol increased [Ca(2+)](i) transient amplitude and Ca(2+) spark frequency to the same extent in wild-type and RyR2(R4496C) cells, indicating that the beta-adrenergic sensitivity of RyR2(R4496C) cells remained unaltered. This effect was independent of protein expression variations because no difference was found in the total or phosphorylated RyR2 expression levels. In conclusion, the arrhythmogenic potential of the RyR2(R4496C) mutation is attributable to the increased Ca(2+) sensitivity of RyR2(R4496C), which induces diastolic Ca(2+) release and lowers the threshold for triggered activity.
Insights
Mutations in the cardiac ryanodine receptor (RyR2) cause catecholaminergic polymorphic ventricular tachycardia by increasing RyR2
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Cardiac ryanodine receptor (RyR2) mutations are linked to catecholaminergic polymorphic ventricular tachycardia (CPVT).
- Altered intracellular calcium (Ca2+) handling is implicated in CPVT pathogenesis.
Purpose of the Study:
- To investigate the Ca2+ handling defect in cardiomyocytes with the RyR2(R4496C) mutation.
- To elucidate the mechanism by which RyR2 mutations lead to cardiac arrhythmias.
Main Methods:
- Cardiomyocytes from heterozygous RyR2(R4496C) knock-in mice and wild-type littermates were used.
- Intracellular Ca2+ ([Ca2+]i) transients were measured using confocal microscopy and fluo-3 fluorescence.
- Ca2+ release and spark frequency were analyzed under various stimulation rates and beta-adrenergic stimulation.
Main Results:
- RyR2(R4496C) cardiomyocytes exhibited abnormal diastolic Ca2+ release, manifesting as Ca2+ waves and delayed afterdepolarizations.
- Increased Ca2+ spark frequency and enhanced Ca2+ sensitivity of RyR2(R4496C) were observed.
- Beta-adrenergic stimulation increased Ca2+ transient amplitude and spark frequency similarly in both mutant and wild-type cells, indicating unaltered beta-adrenergic sensitivity.
Conclusions:
- The RyR2(R4496C) mutation increases RyR2 Ca2+ sensitivity, leading to arrhythmogenic diastolic Ca2+ release.
- This diastolic Ca2+ release lowers the threshold for triggered activity, contributing to CPVT.
- The study identifies increased Ca2+ sensitivity as the key arrhythmogenic mechanism of the RyR2(R4496C) mutation.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Cardiomyopathy I: Introduction and Classification
Dysrhythmias II: Classification of Tachyarrhythmias

